Silence Therapeutics (SLN) Operating Expenses (2024 - 2026)
Silence Therapeutics (SLN) reported Operating Expenses of $16.1 million for Q1 2026, up 13245.45% on a YoY basis from N/an in Q1 2025, and up 272.42% sequentially from $4.3 million in Q4 2025.
Silence Therapeutics (SLN) Operating Expenses (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Operating Expenses data on file, last reported at $16.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 13245.45% year-over-year to $16.1 million; the trailing twelve-month figure through Mar 2026 stood at $42.8 million (down 15.95% YoY), and the FY2025 full-year result was $28.5 million, up 250.95% from the prior year.
- Operating Expenses improved to $16.1 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $45.7 million in Q4 2024 to a low of -$3.9 million in Q2 2024.
- A 3-year average of $10.0 million and a median of $4.3 million in 2025 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses tumbled 90.51% in 2025 and soared 13245.45% in 2026, its largest moves.
- Tracing SLN's Operating Expenses over 3 years: stood at $45.7 million in 2024, then plunged by 90.51% to $4.3 million in 2025, then surged by 272.42% to $16.1 million in 2026.
- Business Quant data shows SLN's Operating Expenses at $16.1 million in Q1 2026, $4.3 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Silence Therapeutics | 1.59 Bn | 1.45 Bn | 411,000.00 | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.15 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 18.94 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 45.71 Mn |
| Sep 30, 2024 | 8.96 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -3.51 Mn |